3. RESPIRATORY PATHOGEN
PANEL (RPP)
• SIMPLICITY OF A SINGLE SPECIMEN
• NEXT DAY RESULTS WITH OPTIONAL ANTIBIOTIC RESISTANCE AND
RX GUIDANCE
• CO-DETECTION OF PATHOGENS WITH CONCENTRATIONS THAT
INDICATE MULTIPLE PATHOGENS AS A CAUSE OF THE INFECTION
• KNOW DEFINITIVELY IF THE CAUSATIVE PATHOGEN(S) IS A VIRUS,
BACTERIA, OR BOTH
• ANTIBIOTIC RESISTANCE DETECTED ON A GENETIC LEVEL,
ALLOWING THE PROVIDER TO PREPARE AN ANTIBIOTIC CLASS
AVOIDANCE STRATEGY
Pg. 1
4. GASTROINTESTINAL
• GENERAL SWAB COLLECTION. NO FECAL
COLLECTION REQUIRED
• 22 TARGETS FROM SINGLE SPECIMEN
• DETECTS DIFFICULT TO CULTURE PATHOGENS
• MULTIPLE BACTERIA TARGETED WITH
RESISTANCE MECHANISMS: WHEN
COMPLIMENTED WITH OUR ANTIBIOTIC
RESISTANCE PANEL, APPROPRIATE
ANTIBIOTIC THERAPY AVAILABLE “NEXT
DAY”
• REDUCE UNNECESSARY PRESCRIBING OF
BROAD SPECTRUM ANTIBIOTICS
• AT THE HEIGHT OF SWIMMING SEASON,
NOROVIRUS IS PREVALENT IN THE PEDIATRIC
COMMUNITY AS CHILDREN SWIM IN LAKES,
RIVERS, AND SWIMMING POOLS WHERE THE
VIRUS IS EASILY SPREAD
Pg. 2
5. URINARY TRACT INFECTIONS
AND SEXUALLY TRANSMITTED
INFECTIONS
• A SINGLE URINE SPECIMEN TARGETS 20 PATHOGENS FOUND
TO CAUSE URINARY TRACT INFECTIONS AND SEXUALLY
TRANSMITTED DISEASES
• SYMPTOMATIC WOMEN CAN VISIT THEIR CLINIC AND A NURSE
CAN QUICKLY COLLECT A STANDARD URINE SPECIMEN.
DEFINITIVE RESULTS ARE AVAILABLE THE FOLLOWING DAY
• UTI’S ARE PREVALENT IN LONG TERM CARE FACILITIES; PRIMARILY
AMONG PATIENTS WITH URINARY CATHETERS
• UTI’S ARE COMMON HEALTHCARE ACQUIRED INFECTIONS
(HAI’S)
• OUR TEAM WILL ASSIST IMPLEMENTING OUR TECHNOLOGY
INTO YOUR ANTIMICROBIAL STEWARDSHIP PROGRAM
Pg. 3
6. WOUND
CARE
• GENERAL SWAB OF THE WOUND YEILDS NEXT DAY RESULTS WITH 99.8% SENSITIVITY & SPECIFICITY
• E. COLI, METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS (MRSA), VANCOMYCIN RESISTANT
ENTEROCOCCI, ALONG WITH SEVERAL ADDITIONAL ANTIBIOTIC RESISTANT STRAINS CAN BE DETECTED
WHEN ACCOMPANIED WITH OUR ANTIBIOTIC RESISTANCE PANEL
• DIFFICULT TO TREAT WOUND INFECTIONS ARE OFTEN CAUSED BY RESISTANT STRAINS OF BACTERIA
THAT CAN BE IDENTIFIED AND, PLACED IN THE HANDS OF OUR PHARMACY TEAM, CAN DEMONSTRATE
IMPROVED PATIENT OUTCOMES WHEN PLACED ON AN APPROPRIATE TREATMENT PLAN
Pg. 4
7. Leaders In Molecular
Diagnostics
THE LEADER IN PROVIDING TRULY ACTIONABLE,
PATIENT-CENTERED REPORTING INCLUDING OUR
UNIQUE PHARMACY MEDICATION REVIEW REPORT
Pg. 5